Asymptomatic carotid stenosis: Intervention or just stick to medical therapy - The case for medical therapy

Journal of Neural Transmission

Volumn 118, Issue 4, 2011, Pages 637-640

  Streifler, Jonathan Y ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Asymptomatic carotid stenosis; Endarterectomy; Medical therapy; Stenting

Indexed keywords

CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; HUMAN; INTERMETHOD COMPARISON; LIFE EXPECTANCY; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE;

CAROTID STENOSIS; CLINICAL PROTOCOLS; HUMANS; STROKE;

EID: 79956198315     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0590-0     Document Type: Review

References (20)

1. Abbott AL, Bladin CF, Levi CR, Chambers BR (2007) What should we do with asymptomatic carotid stenosis? Int J Stroke 2:27-39
2. ACES Investigators (2009) The asymptomatic carotid emboli study: study design and baseline results. Int J Stroke 4:398-405
3. Amarenco P, Labreuche J, Lavallée P, Touboul PJ (2004) Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35:2902-2909 (Pubitemid 39565192)
4. Barnett HJ (2004) Carotid endarterectomy. Lancet 363:1486-1487
5. de Weerd M, Greving JP, de Jong AWF, Buskens E, Bots ML (2009) Prevalence of asymptomatic carotid artery stenosis according to age and sex. Systematic review and mataregression analysis. Stroke 40:1105-1113
6. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study (1995) Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273:1421-1428
7. Goessens BMB, Visseran FLJ, Kappelle J, Algra A, van der Graaf Y, SMART Study Group (2007) Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: the SMART Study. Stroke 38: 1470-1475 (Pubitemid 46684147)
8. Halliday A, Mansfield A, Marro J, MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group et al (2004) Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 363:1491-1502
9. Hobson RW II, Mackey WC, Ascher E et al (2008) Management of atherosclerotic carotid artery disease: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg 48:480-486 (Pubitemid 351997463)
10. Inzitari D, Eliasziw M, Gates P et al (2000) The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med 342:1693-1700
11. Johnson JM, Kennelly MM, Decesare D, Morgan S, Sparrow A (1985) Natural history of asymptomatic carotid plaque. Arch Surg 120:1010-1012 (Pubitemid 16215213)
12. Liapis CD, Bell PRF, Mikhailidis D, On behalf of the ESVS Guidelines Collaborators et al (2009) The European society for vascular surgery (ESVS) guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg 37(Suppl 4):1-19
13. Kang S, Wu Y, Li X (2004) Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis 177:433-442 (Pubitemid 39505278)
14. Nicolaides AN, Kakkos SK, Griffin M et al (2005) Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Eur J Vasc Endovasc Surg 30:275-284
15. Redgrave JN, Rothwell PM (2007) Asmptomatic carotid stenosis: what to do. Curr Opin Neurol 20:58-64
16. Ringleb PA, Chatellier G, Hacke W et al (2008) Safety of endovascular treatment of carotid artery stenosis compared with surgical treatment: a meta-analysis. J Vasc Surg 47:350-355 (Pubitemid 351172672)
17. Rothwell PM, Goldstein LB (2004) Carotid endarterectomy for asymptomatic carotid stenosis: asymptomatic carotid surgery trial. Stroke 35:2425-2427 (Pubitemid 39311274)
18. Sillesen H, Amarenco P, Hennerici MG, Callahan A, Goldstein LB, Zivin J, Messig M, Welch KM (2008) Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke 39:3297-3302
19. Spence JD, Coates V, Li H et al (2010) Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol 67:180-186
20. US Preventive Services Task Force (2007) Screening for carotid artery stenosis: US Preventive Services Task Force Recommendation statement. Ann Intern Med 147:854-859